DREAM5: An open‐label, randomized, cross‐over study to evaluate the safety and efficacy of day and night closed‐loop control by comparing the MD‐Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home

2019 ◽  
Vol 21 (4) ◽  
pp. 822-828 ◽  
Author(s):  
Torben Biester ◽  
Judith Nir ◽  
Kerstin Remus ◽  
Alon Farfel ◽  
Ido Muller ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Delivery System ◽  
Closed Loop ◽  
Closed Loop Control ◽  
Open Label ◽  
Pump Therapy ◽  
Safety And Efficacy ◽  
Loop Control ◽  
Insulin Delivery System

1. Closed-Loop Control with DIAS vs. Sensor-Augmented Pump Therapy in Adolescents and Young Adults with Type 1 Diabetes at Camp (99-L)

2015 ◽  
Vol 13 (3) ◽  
pp. 55-56 ◽  
Author(s):  
Trang T. Ly ◽  
Daniel Cherñavvsky ◽  
Marta Satin-Smith ◽  
Daniel J. Desalvo ◽  
Satya Shanmugham ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Young Adults ◽  
Closed Loop ◽  
Adolescents And Young Adults ◽  
Closed Loop Control ◽  
Pump Therapy ◽  
Loop Control

1065-P: The Effect of a Closed-Loop Insulin Delivery System on Glycemic Control in Type 1 Diabetes

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1065-P ◽  
Author(s):  
ANASTASIOS KOUTSOVASILIS ◽  
ALEXIOS SOTIROPOULOS ◽  
ANASTASIA ANTONIOU ◽  
VASILIOS KORDINAS ◽  
DESPINA PAPADAKI ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Delivery System ◽  
Closed Loop ◽  
Insulin Delivery ◽  
Insulin Delivery System
Sign in / Sign up

Export Citation Format

Share Document